Research suggests that immune cell activity influences pain recovery differences between sexes — Evidence Review

New research suggests that women experience longer-lasting pain after injury than men, likely due to differences in immune cell function and hormone-driven signaling; related studies generally support these findings of sex-based differences in pain recovery and immune responses, as highlighted by research from Michigan State University.

• Multiple studies consistently report that women experience more severe, frequent, and prolonged pain than men, with a higher risk for chronic pain development and disability 1 2 4 12 13.
• Several reviews and experimental studies indicate that genetic, hormonal (including testosterone and estrogen), and immune factors—such as differences in cytokine and immune cell responses—contribute to these sex differences in pain perception and recovery 2 3 6 7 8 10.
• While the new study highlights a specific role for IL-10–producing monocytes and testosterone in pain resolution for males, related research both supports enhanced IL-10 production in males under some immune stimuli 7 and notes complexities in cytokine responses that may depend on the context and type of immune challenge 8 9 10.

Study Overview and Key Findings

Chronic pain disproportionately affects women, yet the underlying biological mechanisms driving this difference have remained unclear. Historically, sex-based disparities in pain recovery were often attributed to psychosocial factors, leading to inadequate recognition of biological contributors. This new study provides timely insight by investigating the role of immune cells—and their interaction with sex hormones—in the resolution of pain after injury, using both animal models and human data from people involved in motor vehicle collisions. These findings offer a potential biological explanation for why women may be more susceptible to chronic pain, moving beyond prior assumptions that focused mainly on psychological or social influences.

Property	Value
Organization	Michigan State University
Authors	Dr. Geoffroy Laumet
Population	Mice and people involved in motor vehicle collisions
Methods	Animal Study
Outcome	Levels of IL-10 and pain recovery rates
Results	Males recover from pain faster; IL-10 production differs by sex.

Literature Review: Related Studies

To situate these findings in the broader scientific context, we searched the Consensus database, which includes over 200 million research papers. The following queries were used to identify relevant studies:

1. pain duration gender differences
2. IL-10 immune response sex comparison
3. chronic pain recovery rate males females

Below, we group the main themes emerging from the literature and summarize key findings.

Topic	Key Findings
Why do pain duration and chronic pain risk differ between men and women?	- Women consistently report more severe, frequent, and longer-lasting pain compared to men 1 2 4. - Female gender is a strong predictor of slower recovery and worse outcomes in conditions like sciatica and neuropathic pain 12 13.
How do immune cell responses and cytokines (including IL-10) differ by sex?	- Males often have stronger monocyte-derived cytokine responses to immune stimuli, with some studies showing higher IL-10 production in males, influenced by sex hormones 7 8 10. - Sex hormones and genetics modulate immune responses 6 7.
What role do psychosocial and hormonal factors play in pain sensitivity and recovery?	- Psychosocial and hormonal factors both contribute to pain sensitivity and recovery, with sex hormones influencing immune function and pain processing 2 3 6. - Gender roles and coping strategies can affect pain expression and management 2 4.
How do men and women respond to pain treatments and interventions?	- Women often show greater improvements after multimodal pain treatment, but may have less sustained benefits or greater likelihood of treatment discontinuation due to persistent pain 5 11 14 15. - Response to device-based treatments is similar 15.

Why do pain duration and chronic pain risk differ between men and women?

A substantial body of literature demonstrates that women are more likely than men to experience intense, frequent, and prolonged pain, as well as to develop chronic pain conditions. This trend is observed in both clinical and experimental settings and is not limited to a single type of pain or injury. The new study aligns with these patterns, providing mechanistic evidence that differences in immune cell behavior and hormonal signaling may underpin these sex-based disparities in pain outcomes.

• Multiple reviews and clinical studies report higher prevalence, severity, and duration of pain in women compared to men 1 2 4.
• Prospective studies on specific conditions, such as sciatica and neuropathic pain, find that women recover more slowly and have worse long-term outcomes 12 13.
• The findings from the new study, focusing on immune and hormonal mechanisms, offer a biological explanation for these observed differences 13.
• These disparities may contribute to the higher risk of pain-related disability and chronic pain in women 1 4 12.

How do immune cell responses and cytokines (including IL-10) differ by sex?

Sex-based differences in immune responses are increasingly recognized as important contributors to health disparities, including pain outcomes. Several studies have found that males often exhibit stronger monocyte-derived cytokine responses to immune challenges, including in the production of IL-10, an anti-inflammatory cytokine implicated in pain resolution. The new study extends this by directly linking IL-10 production to pain recovery and demonstrating hormonal regulation of this pathway.

• Males may produce higher levels of IL-10 and other cytokines in response to certain immune stimuli, an effect modulated by sex hormones 7 8 10.
• The current study's finding that testosterone enhances IL-10 production in male monocytes is supported by data showing hormone-dependent differences in cytokine responses 6 7.
• Some studies note that the context of immune activation (e.g., type of stimulus, acute vs. chronic inflammation) can influence the magnitude and direction of sex differences in cytokine production 8 9 10.
• Genetic factors and early-life exposures may further shape sex-specific immune responses 6.

What role do psychosocial and hormonal factors play in pain sensitivity and recovery?

While biological mechanisms are increasingly acknowledged, psychosocial and hormonal factors remain important in explaining sex differences in pain. Research highlights the influence of sex hormones, such as estrogen and testosterone, as well as psychological and social factors—including gender roles, coping behaviors, and stress exposure—on pain perception and recovery.

• Sex hormones modulate both immune function and pain sensitivity, with emerging evidence that they may directly affect pain resolution pathways 2 3 6.
• Gender roles and expectations can impact how pain is reported and managed, potentially contributing to observed disparities 2 4.
• Early-life stress and coping strategies are additional factors that may differentially affect men and women in their experience and reporting of pain 2 3.
• The new study's identification of testosterone's role in promoting pain resolution via IL-10 complements prior findings regarding the intersection of hormonal and immune influences 6 7.

How do men and women respond to pain treatments and interventions?

The literature indicates that while women may report more pain and slower recovery, they sometimes respond more favorably to certain pain management interventions, though these benefits may not always be sustained. Device-based treatments, such as spinal cord stimulation, appear equally effective for both sexes, though reasons for discontinuation may differ.

• Women often experience greater improvements in pain and disability after multimodal pain management programs, though they may be less likely to maintain these gains over time 5 11 14.
• Men and women respond similarly to neuromodulation therapies, but women are more likely to discontinue due to insufficient pain relief, while men more often have device complications 15.
• Differences in pain recovery may influence the long-term effectiveness of interventions and highlight the need for sex-specific approaches 5 11 14 15.
• These findings suggest that optimizing pain management may require tailoring strategies to account for sex-based biological and psychosocial differences 2 5 14.

Future Research Questions

Further research is needed to clarify the interplay between immune cell function, sex hormones, and pain outcomes, and to develop interventions that account for these differences. Key questions remain about the generalizability of IL-10–mediated pain resolution to different types of pain, the influence of other immune pathways, and the potential for targeted therapies.

Research Question	Relevance
How do sex hormones modulate immune cell function in chronic pain conditions?	Understanding the hormonal regulation of immune cells is crucial for developing sex-specific pain therapies and may explain why women are at higher risk for chronic pain 2 6 7.
Can enhancing IL-10 production improve pain recovery in females?	Targeting IL-10 pathways could offer new treatments for chronic pain, particularly in women who exhibit lower IL-10 responses after injury 7 13.
What are the genetic determinants of sex differences in pain resolution?	Genetic variation may underlie individual and sex-based differences in immune and pain pathways, informing personalized medicine approaches 3 6.
How do psychosocial factors interact with immune mechanisms to influence pain outcomes?	Integrating biological and psychosocial perspectives is essential for a comprehensive understanding of chronic pain and for designing effective interventions 2 4.
Are there differences in pain resolution mechanisms between acute and chronic pain across sexes?	Clarifying whether the same immune and hormonal mechanisms operate in both acute and chronic pain may help identify critical intervention windows 3 13.